Synthetic Hormones Market Trends, Drivers, and Regional Analysis 2025–2029

Uncover key drivers, emerging technologies, and competitive movements shaping the synthetic hormones market from 2025–2034 with trusted insights from The Business Research Company

How Is The Synthetic Hormones Market Size Expected To Expand Over 2029-2034?

The cyclosporine market has experienced rapid expansion in recent years. Its valuation is set to climb from $2.65 billion in 2024 to $2.98 billion in 2025, propelled by a compound annual growth rate (CAGR) of 12.6%. In the past, this market’s expansion was primarily driven by an escalating volume of organ transplant procedures, an uptick in autoimmune disease diagnoses, a rise in chronic ailments, a surge in kidney-related conditions, and the establishment of more transplant centers.

The cyclosporine market is projected to experience substantial expansion in the coming years. Its value is anticipated to reach $4.85 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 12.9%. This growth during the forecast period is attributable to an increase in organ donations, wider adoption of immunotherapy, a growing elderly patient population, an expanding specialty pharmaceutical sector, and a higher occurrence of rheumatoid arthritis. Key trends anticipated for the forecast period encompass the creation of new immunosuppressive treatments, breakthroughs in AI-powered drug development, progress in nanotechnology integration, innovations in blockchain technology within the drug supply chain, and improvements in drug delivery methods.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23360&type=smp

Which Market Factors Are Fueling The Synthetic Hormones Industry Growth?

An increasing incidence of autoimmune conditions is anticipated to drive expansion in the cyclosporine market moving forward. These diseases are characterized by the immune system erroneously targeting the body’s healthy cells, leading to inflammation, harm to tissues, and persistent sickness. The uptick in autoimmune disease prevalence stems from genetic predispositions, as improved genetic testing helps pinpoint more people with inherited risks, thereby increasing their vulnerability to such ailments. Cyclosporine demonstrates efficacy in managing autoimmune diseases by inhibiting T-cell activation, which consequently lessens detrimental immune reactions against healthy tissues in conditions like rheumatoid arthritis, psoriasis, and lupus. As an illustration, in May 2024, a report from the National Institutes of Health (NIH), a US government agency, indicated that in 2022, psoriatic arthritis (PsA) had a prevalence of 0.221% and an incidence rate of 13.54 per 100,000 individuals. Consequently, the increasing occurrence of autoimmune diseases is fueling the expansion of the cyclosporine market.

Which Categories Are Covered In The Synthetic Hormones Market Segmentation Analysis?

The cyclosporine market covered in this report is segmented –

1) By Indication: Transplant Rejection Prophylaxis, Rheumatoid Arthritis, Psoriasis, Autoimmune Myasthenia Gravis, Dry Eye, Other Indications

2) By Dosage Form: Capsule, Eye Drops, Liquid Solutions, Creams And Ointments

3) By Route Of Administration: Oral, Topical, Parenteral

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End-Users: Hospitals, Homecare, Speciality Centres, Other End-Users

Subsegments:

1) By Transplant Rejection Prophylaxis: Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Other Transplants

2) By Rheumatoid Arthritis: Moderate Rheumatoid Arthritis, Severe Rheumatoid Arthritis

3) By Psoriasis: Plaque Psoriasis, Erythrodermic Psoriasis, Guttate Psoriasis, Pustular Psoriasis

4) By Autoimmune Myasthenia Gravis: Generalized Myasthenia Gravis, Ocular Myasthenia Gravis

5) By Dry Eye: Chronic Dry Eye, Severe Dry Eye

6) By Other Indications: Atopic Dermatitis, Uveitis, Nephrotic Syndrome, Inflammatory Bowel Disease (IBD)

Which Market Trends Are Expected To Define The Future Of The Synthetic Hormones Market?

Leading companies within the cyclosporine market are strategically pursuing regulatory approvals to broaden their product portfolios and strengthen their footprint in the market. Such regulatory endorsements validate the safety and effectiveness of cyclosporine, thereby granting market access and enhancing the trust of both prescribers and patients. For example, in June 2023, the German biopharmaceutical company Novaliq GmbH secured approval from the U.S. FDA for VEVYE (cyclosporine ophthalmic solution) 0.1%. This innovative water-free ophthalmic drug is specifically developed for managing dry eye disease (DED). Notably, it is the inaugural and sole cyclosporine-based solution available for this ailment, demonstrating efficacy in as little as four weeks. VEVYE incorporates an advanced water-free technology called EyeSol, which improves cyclosporine’s bioavailability and prolongs its presence on the ocular surface, all without relying on preservatives, oils, or surfactants. Functioning as a calcineurin inhibitor, the solution contributes to reducing the inflammation associated with dry eye disease.

Which Organizations Are At The Forefront Of The Synthetic Hormones Market?

Major companies operating in the cyclosporine market are Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd, Apotex Inc., Cipla Ltd, Dr. Reddy’s Laboratories Ltd, Lupin Limited, Glenmark Pharmaceuticals Ltd, Taj Pharmaceuticals Limited, Panacea Biotec Ltd, Novaliq GmbH, Simson Pharma Limited, Strides Pharma Science Ltd, AdvaCare Pharma, JoinHub Pharma, Grevis Pharmaceuticals Pvt Ltd, GMT Pharma International, Logos Pharma.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cyclosporine-global-market-report

Which Geographic Areas Are Driving Strong Demand For The Synthetic Hormones Market?

Asia-Pacific was the largest region in the cyclosporine market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the cyclosporine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=23360&type=smp

Browse Through More Reports Similar to the Global Synthetic Hormones Market 2025, By The Business Research Company

Connected Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/connected-drug-delivery-devices-global-market-report

Controlled Release Drug Delivery Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

Covid19 Drug Associated Api Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/covid19-drug-associated-api-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795